Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	615.22	925.27	1,439	1,925	98.24
Short-Term Investments	0	0	63.76	362.13	313.99
Cash & Cash Equivalents	615.22	925.27	1,503	2,287	412.23
Cash Growth	-33.51%	-38.43%	-34.30%	454.87%	-
Receivables	126.86	109.95	134.59	110.96	163.19
Inventory	69.02	130.32	123.21	68.02	58.12
Other Current Assets	73	93.22	60.28	57.33	73.25
Total Current Assets	884.1	1,259	1,821	2,524	706.79
Property, Plant & Equipment	144.2	300.03	406.45	111.48	89.31
Long-Term Investments	5.66	5.8	0.91	1.42	40.16
Goodwill and Intangibles	0.96	1.99	5.15	3.46	0.34
Other Long-Term Assets	5.09	20.89	45.14	23.02	10.95
Total Long-Term Assets	155.91	328.71	457.64	139.38	140.77
Total Assets	1,040	1,587	2,279	2,663	847.56
Accounts Payable	18.06	50.95	63.08	35.48	12.35
Deferred Revenue	130.54	147.63	142.87	74.67	50.53
Current Debt	8.63	37.24	37.37	46.88	44.39
Other Current Liabilities	106.13	175.64	128.86	84.51	57.17
Total Current Liabilities	263.36	411.45	372.18	241.53	164.44
Long-Term Debt	3.69	13.55	49.32	0	23.08
Other Long-Term Liabilities	4.54	4.12	11.78	0.49	24.49
Total Long-Term Liabilities	8.23	17.68	61.09	0.49	47.58
Total Liabilities	271.59	429.13	433.28	242.02	212.02
Total Debt	12.32	50.79	86.69	46.88	67.47
Debt Growth	-75.73%	-41.41%	84.90%	-30.52%	-
Retained Earnings	-3,853.64	-3,199.95	-2,228.71	-1,418.16	-946.46
Comprehensive Income	-161.53	-165.72	-207.07	-167.59	9.3
Shareholders' Equity	768.41	1,158	1,845	2,421	-891.49
Net Cash / Debt	602.89	874.48	1,416	2,240	344.76
Net Cash / Debt Growth	-31.06%	-38.25%	-36.79%	549.86%	-
Net Cash Per Share	5.89	8.42	13.59	32.64	14.11
Working Capital	620.73	847.31	1,449	2,282	542.35
Book Value Per Share	7.50	11.15	17.71	35.27	-36.48

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).